483
Aurobindo Pharma LtdAurobindo Pharma Ltd – FDA 483, May 24, 2019
Record Details
Aurobindo Pharma Ltd in Medchal, India, received a Form 483 with 10 observations during an inspection from May 13-24, 2019. The observations highlight significant deficiencies in quality control, data integrity, equipment cleaning, complaint handling, and computer system controls, indicating a lack of adherence to cGMP regulations. These issues raise concerns about the quality and reliability of drug products manufactured at the facility.
View Company Profile
ID · ed01b8a9-88db-401b-b91c-4b4446c83461
Other documents for Aurobindo Pharma Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.